In the early 1990’s, rehabilitation facilities did indeed experience a significant surge of patients who were “addicted” to cannabis. But a survey done at that time noted that nearly all of them had come from the court system, where judges gave convicted criminals the choice between entering into treatment for addiction or entering prison, which was probably a pretty simple choice for most.
Currently available pharmacological treatments include serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors, benzodiazepines, monoamine oxidase inhibitors, tricyclic antidepressant drugs, and partial 5-hydroxytryptamine (5-HT)1A receptor agonists. Anticonvulsants and atypical antipsychotics are also used to treat PTSD. These medications are associated with limited response rates and residual symptoms, particularly in PTSD, and adverse effects may also limit tolerability and adherence [7–10]. The substantial burden of anxiety-related disorders and the limitations of current treatments place a high priority on developing novel pharmaceutical treatments.
CBD oil is a relatively new product to the high street health market, meaning the burning questions are coming in thick and fast. And what better way to find out all the answers than to take a trip to Celtic Wind Crops' cannabis farm in County Louth, Ireland, where they grow hemp and manufacture the 5% strength CBD oil (and powder, and capsules) that has become the first CBD product to be sold in a UK Pharmacy (LloydsPharmacy). Here's everything I learned:
Relevant studies in animal models are summarized in chronological order in Table Table1.1. CBD has been studied in a wide range of animal models of general anxiety, including the elevated plus maze (EPM), the Vogel-conflict test (VCT), and the elevated T maze (ETM). See Table Table11 for the anxiolytic effect specific to each paradigm. Initial studies of CBD in these models showed conflicting results: high (100 mg/kg) doses were ineffective, while low (10 mg/kg) doses were anxiolytic [59, 60]. When tested over a wide range of doses in further studies, the anxiolytic effects of CBD presented a bell-shaped dose–response curve, with anxiolytic effects observed at moderate but not higher doses [61, 90]. All further studies of acute systemic CBD without prior stress showed anxiolytic effects or no effect [62, 65], the latter study involving intracerebroventricular rather than the intraperitoneal route. No anxiogenic effects of acute systemic CBD dosing in models of general anxiety have yet been reported. As yet, few studies have examined chronic dosing effects of CBD in models of generalized anxiety. Campos et al.  showed that in rat, CBD treatment for 21 days attenuated inhibitory avoidance acquisition . Long et al.  showed that, in mouse, CBD produced moderate anxiolytic effects in some paradigms, with no effects in others.
But when it comes to pain management, one of the primary uses for CBD oil, deaths from drug overdoses and drug poisoning continue to rise. Deaths from opioid analgesics – one of the most universally prescribed pain management drugs – increased from 4,030 in 1999 to 15,597 in 2009 and 16,651 in 2010. In 2010, 60 percent of all drug overdose deaths (22,134) involved pharmaceutical drugs, and opioid analgesics showed up in about 3 of every 4 of those pharmaceutical overdose deaths. That confirms the predominant role that research has shown opioid analgesics to play in drug-related mortality. Opioids are nasty, brutal drugs with side effects nearly as bad as the conditions they’re taken for, and although deaths from opioids are common, they’re still one of the most turned to bandaids in modern medicine.
The founder of Elixinol got his start in the hemp industry back in 1991, when he launched a “9bar,” a healthy snack bar packed with heart-healthy hemp which remains one of the world’s most popular hemp products. Elixinol sells an array of CBD products, including Tinctures, Capsules, Liposomes, Vape Liquids, and Topical Balms, all of which contain the purest-possibly hemp. The company sources hits hemp from farms in Europe, Australia, and America, uses a chemical- and heat-free, broad-spectrum CO2 extraction process, and employs a team of medical professionals to research and develop their product formulations. Most impressive, however, is the company’s standards of testing, which is conducted both in house and third-party, and which covers potency, microbiological contamination, heavy metals, pesticides, and terpene profile. The European-based labs employ equipment and personnel from the pharmaceutical industry, and all test results are posted online alongside product listings. There are a few contenders for best CBD oil for anxiety in their product selection. Their original and cinnamint-flavored CBD tinctures are most popular, and come in strengths of in dosages of 300 or 600 mg per 15 ml bottle, or 3,600 mg per 120 ml (or, available for order from Brazil only, a heavy-duty 5,000 mg). The blend contains CBD suspended in hemp oil, plus Amino acids, Natural Sugars, Aldehydes, Alcohols, Ketones, Flavanoids, Glycosides, and Vitamins. Those In search of a portable CBD for anxiety can try their 15 mg CBD capsules, 300 mg or 600 mg oral spray, or Elixinol’s proprietary “X-Pen”, which is pre-loaded with 1,000 mg CBD and delivers precise dosages on-the-go.
For some reason, Monday morning doesn't seem full of the usual oh my goodness, there could be a disaster around every corner situations I normally conjure up in my mind. Maybe it's because it's sunny outside (always a bonus); maybe it's because my brain is fuzzy with phlegm; maybe it's because my nose piercing, fed up with endless nose-blowing, is pulsating in pain. Maybe it's the oil. Either way, I spend the afternoon praising the oil, wishing I could bathe in it. The phlegm may be causing me to lose it a little.
 N. M. Kogan, E. Melamed, E. Wasserman, B. Raphael, A. Breuer, K. S. Stok, R. Sondergaard, A. V. Escudero, S. Baraghithy, M. Attar-Namdar, S. Friedlander-Barenboim, N. Mathavan, H. Isaksson, R. Mechoulam, R. Müller, A. Bajayo, Y. Gabet, and I. Bab, “Cannabidiol, A Major Nonpsychotropic Cannabis Constituent, Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts,” Journal of Mineral and Bone Research 30, no. 10 (October 2015): 1905–1913.
I have been using cannabidiol for going on two years now and I will say this – I believe it is very, very difficult to find a dispensary that carries ACTUAL high-CBD cannabis. I have smoked ACDC with supposedly nearly zero THC and gotten higher than if had hit a 1/2 g dab of sour diesel. Honestly there needs to be some sort of regulation about this cannabinoid profiles that the dispensaries put on their strains because in my experience they are NOT accurate
The human body also produces cannabinoids, known as endocannabinoids, in a bodily system known as the endocannabinoid system (or ECS). The ECS promotes homeostasis by regulating a wide range of functions, including motor skills, mood, appetite, and sleep. As we age, our ECS produces fewer endocannabinoids; they may also decrease due to physical injury or disease. Replenishing depleted endocannabinoids with phytocannabinoids like CBD can help restore balance to the body.
Scientific studies support ashwagandha’s ability not only to relieve stress, but also to protect brain cells against the deleterious effects of our modern lifestyles. For example, in validated models of anxiety and depression, ashwagandha has been demonstrated to be as effective as some tranquilizers and antidepressant drugs. Specifically, oral administration of ashwagandha for five days showed anxiety-relieving effects similar to those achieved by the anti-anxiety drug lorazepam (Ativan®), and antidepressant effects similar to those of the prescription antidepressant drug imipramine (Tofranil®).
Have a high-stress job with an important pitch or presentation coming up? The fear of public speaking or intimidating social interactions is one of the most common forms of anxiety. For some, social anxiety simply makes parties, work gatherings, or a daily job uncomfortable and exhausting. For others with social anxiety, it is a crippling fear that keeps them locked indoors and in isolation.
An animal study using mice found repeated administration of CBD may help the hippocampus regenerate neurons, which could be useful for treating anxiety or depression. Research shows both SSRIs and CBD may promote neurogenesis. This is significant, because evidence suggests that severely impaired neuronal plasticity may influence suicidal behavior. Future research comparing CBD and SSRIs effect on neurogenesis could open up promising new avenues in how we understand depression and how to most effectively treat it.
Epidemiological studies of various neuropsychiatric disorders indicate that a higher CBD content in chronically consumed cannabis may protect against adverse effects of THC, including psychotic symptoms, drug cravings, memory loss, and hippocampal gray matter loss [115–118] (reviewed in ). As THC acutely induces anxiety, this pattern may also be evident for chronic anxiety symptoms. Two studies were identified, including an uncontrolled retrospective study in civilian patients with PTSD patients , and a case study in a patient with severe sexual abuse-related PTSD , which showed that chronic cannabis use significantly reduces PTSD symptoms; however, these studies did not include data on the THC:CBD ratio. Thus, overall, no outcome data are currently available regarding the chronic effects of CBD in the treatment of anxiety symptoms, nor do any data exist regarding the potential protective effects of CBD on anxiety potentially induced by chronic THC use.
2.) What a fantastic study with such positive results! In a nation (United States) where 1 out of 3 people suffer from diabetes, WE NEED MORE STUDIES! This was an animal study, but great results for CBD hemp oil to be a potential health benefit for humans. Here’s what the study stated, “We now report that CBD potentially relievement significantly reduces the incidence of diabetes in NOD mice from an incidence of 86% in non-potentially relieveed control mice to an incidence of 30% in CBD-potentially relieveed mice.” View Source
Cannabidiol has been found to act as an antagonist of GPR55, a G protein-coupled receptor and putative cannabinoid receptor that is expressed in the caudate nucleus and putamen in the brain. It has also been found to act as an inverse agonist of GPR3, GPR6, and GPR12. Although currently classified as orphan receptors, these receptors are most closely related phylogenetically to the cannabinoid receptors. In addition to orphan receptors, CBD has been shown to act as a serotonin 5-HT1A receptor partial agonist, and this action may be involved in its antidepressant, anxiolytic, and neuroprotective effects. It is an allosteric modulator of the μ- and δ-opioid receptors as well. The pharmacological effects of CBD have additionally been attributed to PPARγ agonism and intracellular calcium release.
The store-bought hemp products typically contain hemp seed oil that provides just trace amounts of cannabidiol and thus they can’t be considered as a CBD supplement. The top quality CBD oil is obtained from the stalks of the selected hemp cultivars. It provides the higher percentages of cannabidiol by weight and provides some astonishing medical perks.
Only recently, marijuana and chemically-related compounds have come back to being considered of therapeutic value. A prominent compound found in marijuana or cannabis, CBD, or cannabidiol, has been shown to treat numerous diseases. Researchers believe that in view of the very low toxicity and the generally benign side effects of CBD, neglecting or denying CBD benefits and its clinical potential is simply unacceptable.
If you have ever suffered from anxiety, then you know that it is awful, and it would be the same for your dog too. Many dogs suffer from anxiety and have been known to be depressed and extremely anxious in certain situations, such as when their owner leaves. This can result in destructive behaviors such as chewing objects, urinating, pacing, and more. CBD helps because it is a relaxing stimulant that calms your pet.
Another field in which CBD is creating a buzz is in the area of mood disorders like anxiety and depression. Both conditions have been treated with a variety of medications, courtesy of Big Pharma, that have had varying levels of success. Again, the long list of side effects can be off-putting to someone who just wants to get through the day without the sweaty tension of anxiety or the gray haze of depression.
A 2012 research review assessed a number of international studies and concluded that CBD has been shown to reduce anxiety, and in particular social anxiety, in multiple studies and called for more clinical trials. Two years later, researchers in an animal study related to stress and the endocannabinoid system wrote that augmentation of the endocannabinoid system might be an effective strategy to mitigate behavioral and physical consequences of stress.
In the video, you learn about one study in which researchers found that pot smokers had lower levels of obesity than people who do not smoke pot, and another study that found that a brain chemical with a structure similar to one of the active compounds found in cannabis might actually help people lose weight. The findings are just the latest addition to a growing body of evidence that marijuana may be useful in countering issues related to obesity.
While normally I'd be slightly tripped up by little things like an overly crowded subway car or a full inbox at work, the CBD oil seems to have taken the edge off of my anxiety a bit. Rather than overthinking a sternly worded email or analyzing a social interaction, I've found it easier to recognize the irrationality of these thoughts and actually let them go (instead of ruminating on the situation). In some ways, I feel more like myself. With that said, I've still experienced some social anxiety when meeting new groups of people—I'd be interested to see what taking the full recommended dose would do.